ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $694 | -100.0% | 33,304 | -39.3% | 0.04% | -62.0% |
| Q4 2020 | $2,934,000 | +28.6% | 54,880 | -0.7% | 0.10% | +33.3% |
| Q3 2020 | $2,281,000 | -16.7% | 55,280 | -2.1% | 0.08% | 0.0% |
| Q2 2020 | $2,737,000 | -46.5% | 56,470 | -53.4% | 0.08% | -51.0% |
| Q1 2020 | $5,113,000 | -3.9% | 121,051 | -2.7% | 0.15% | +25.4% |
| Q4 2019 | $5,320,000 | -9.1% | 124,370 | -23.5% | 0.12% | -6.9% |
| Q3 2019 | $5,851,000 | +477.0% | 162,566 | +348.4% | 0.13% | +322.6% |
| Q1 2016 | $1,014,000 | – | 36,254 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |